value-based care

Interview

Clinical Pathways and Value-Based Care at the Dana Farber Cancer Institute

08/03/2017

JCP Editors

Journal of Clinical Pathways spoke with Aymen Elfiky, MD, MPH, MSc, attending physician, clinical oncology, Dana Farber Cancer Institute (Boston, MA), about clinical pathway implementation at the Institute,...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Benefits and Shortcomings of Oncology Value Frameworks for Payers

08/03/2017

JCP Editors

Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers, according to a study in the Journal of Managed Care & Specialty Pharmacy (June...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Multiple Myeloma Therapies From a Payer‚Äôs Perspective

08/02/2017

JCP Editors

A recent cost-effectiveness analysis compared novel agents and chemotherapy for older Medicare patients with multiple myeloma, published in the Journal of Managed Care & Specialty Pharmacy (August...

A...

08/02/2017

Journal of Clinical Pathways

Interview

ASCO Leads Discussion on Clinical Pathways Strategies, Improvement

07/13/2017

JCP Editors

Journal of Clinical Pathways spoke with Robin Zon, MD, FACP, FASCO, chair of the ASCO Clinical Pathways Task Force, about the current state of pathways, the future state of pathways in oncology care, and...

...

07/13/2017

Journal of Clinical Pathways

Research in Review

Chronic Cancer Survivors in Need of Improved Survivorship Care Plans

06/30/2017

JCP Editors

Survivors of chronic cancer are often not receiving optimal survivorship care plans and follow-up treatment, according to a study published in Cancer (published online June 27, 2017;...

...

06/30/2017

Journal of Clinical Pathways

Research in Review

Clinical Trials Improve Survival, Lower Costs for Patients With Cancer

06/27/2017

JCP Editors

Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...

...

06/27/2017

Journal of Clinical Pathways

Research in Review

High Cost of Care for Older Patients With Brain Tumors at EOL

06/23/2017

JCP Editors

Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...

...

06/23/2017

Journal of Clinical Pathways

Research in Review

Personalized Dosing More Cost-Effective for NSCLC Treatment

06/15/2017

JCP Editors

A recent budget analysis evaluated the costs, safety, and efficacy of personalized dosing compared with fixed dosing of standard-of-care treatment for non-small cell lung cancer, presented at the 2017 ASCO Annual...

A...

06/15/2017

Journal of Clinical Pathways

Feature

Malnutrition Management: A Clinical Pathway Model for Symptom Management

06/14/2017

Nader Tavakoli, MD, CMD, FAAFP

Christopher Riley, MD

Emily Chan, MD

Paul Newman, MD, MBA, MS

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD

Abstract: Although clinical pathways are most often developed for very narrow diagnoses with limited pharmaceutical treatments, they are even more needed to provide direction for symptom management involving multiple...

...

06/14/2017

Journal of Clinical Pathways

Perspectives

Accountable Health Care

06/14/2017

Anita Ballaney, MBA, MCA, BSc

Abstract: Since its passage in 2010, the Patient Protection and Affordable Care Act (ACA) has caused widespread disruption in the US health care ecosystem. This has put a huge spotlight on the system’s shortcomings,...

...

06/14/2017

Journal of Clinical Pathways